Meta tags:
description= Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.;
Headings (most frequently used words):
the, to, our, patients, of, for, more, outcomes, diversity, inclusion, with, global, explore, bms, give, drug, pathway, firsthand, science, matter, better, cancer, treatments, no, lung, researching, tomorrow, platform, or, reach, discovery, investigate, us, research, allow, potential, early, that, discoveries, approaches, strategic, scientists, possible, best, today, curiosity, by, driven, are, pursue, resources, approach, leading, year, full, and, quarter, fourth, 2023, value, answers, results, looking, together, forward, moving, squibb, myers, bristol, company, financial, how, shaping, living, therapy, cell, advancing, biopharmaceutical, media, scientific, colitis, ulcerative, account, is, woman, one, trials, clinical, in, gap, closing, modality,
Text of the page (most frequently used words):
our (23), the (15), #english (14), and (13), for (12), #patients (11), #icon (10), #page (9), #with (9), #research (9), global (9), #medicines (8), #resources (8), #links (8), quick (8), information (8), more (7), learn (7), next (7), clinical (6), about (6), spanish (6), squibb (6), bristol (6), myers (6), careers (5), medical (5), providers (5), healthcare (5), investors (5), business (5), your (4), #cancer (4), media (4), patient (4), diversity (4), help (4), trials (4), how (4), drug (4), company (4), french (4), access (4), development (4), united (4), researchers (4), bms (4), inclusion (4), position (3), from (3), explore (3), science (3), history (3), lives (3), leadership (3), today (3), stories (3), news (3), caregivers (3), german (3), request (3), looking (3), contact (3), are (3), annual (3), areas (3), team (3), financial (2), arabic (2), treatments (2), other (2), portuguese (2), results (2), mexico (2), press (2), that (2), scientific (2), early (2), argentina (2), dutch (2), strategic (2), outcomes (2), pursue (2), czech (2), chinese (2), states (2), report (2), brazil (2), transaction (2), technology (2), system (2), publications (2), releases (2), together (2), interest (2), shareholders (2), stock (2), collaboration (2), post (2), study (2), commitment (2), they (2), pre (2), approval (2), previous (2), biopharmaceutical (2), completes (2), markets (2), mirati (2), contacts (2), world (2), stem (2), 2024 (2), therapeutics (2), locations (2), trial (2), people (2), worldwide (2), main (2), value (2), notice (2), paying (2), find (2), transform (2), shareholder (2), survivorship (2), coverage (2), new (2), forward (2), statement (2), head, thomas, efforts, incubator, independent, daniel, center, moving, pipeline, around, evaluation, risk, immunology, drugs, generic, pricing, psoriasis, focus, sheet, fact, practice, 340b, privacy, legal, navigation, home, grants, perspectives, license, presence, enhancing, b01d1, systimmune, agreement, out, 2022, space, dividend, split, calculator, return, investment, filings, adc, investor, disclosure, process, portal, sponsored, investigator, strategies, competitive, requests, compound, sharing, acquisition, data, reporting, analyst, presentations, events, services, celgene, related, mitigation, pdf, rems, belgium, taiwan, traditional, thailand, thai, europe, austria, republic, zealand, denmark, danish, finland, finnish, france, germany, greece, singapore, korean, hungary, february, skip, close, americas, canada, chile, colombia, peru, pacific, korea, asia, australia, china, simplified, india, japan, japanese, greek, hungarian, get, turkish, east, middle, israel, hebrew, arabia, saudi, turkey, emirates, slavery, arab, human, trafficking, quarterly, distributor, bmsuscqpagelucene, trademarks, kingdom, ireland, polish, italy, italian, luxembourg, netherlands, norway, norwegian, poland, portugal, switzerland, follow, romania, romanian, spain, sweden, swedish, sec, struggling, summary, 2023, change, join, year, full, quarter, fourth, gap, colleagues, closing, colitis, ulcerative, living, account, woman, three, want, better, their, women, america, latin, celebrating, meaningful, into, fascinations, turn, who, stereotypes, defied, share, pull, felt, all, one, give, time, reach, best, survivors, curiosity, driven, scientists, tomorrow, approach, possible, shaping, therapy, cell, advancing, across, country, leading, conversations, series, lung, platform, researching, discovery, through, pathway, firsthand, what, modality, matter, approaches, discoveries, means, potential, investigate, allow, live, first, c2c4c, sales, disease, medication, may, meetings, library, infographics, state, able, ticket, corporate, assist, caring, responsibility, sustainability, week, timeline, golden, contests, foundation, why, product, reports, you, meeting, read, partnerships, partner, understand, download, discussion, begin, alliances, innovation, brochure, pay, critical, groups, riders, never, produce, sustained, strong, completed, announced, forget, milestone, something, was, performance, throughout, themselves, challenge, important, continue, resource, pioneering, part, bringing, issues, key, helpful, answers, innovations, legacy, strengthen, long, strive, build, will, portfolio, oncology, diversify, content,
Text of the page (random words):
global biopharmaceutical company bristol myers squibb our medicines our stories investors skip to main content contact us careers united states close icon americas argentina spanish brazil portuguese canada english french chile spanish colombia spanish mexico spanish peru spanish united states english asia pacific australia english china simplified chinese india english japan japanese korea korean new zealand english singapore english taiwan traditional chinese thailand english thai europe austria german belgium english dutch french czech republic czech denmark danish finland finnish france french germany german greece greek hungary hungarian ireland english italy italian luxembourg english netherlands english dutch norway norwegian poland polish portugal portuguese romania romanian spain spanish sweden swedish switzerland german french united kingdom english middle east israel hebrew saudi arabia english arabic turkey turkish united arab emirates english arabic other other markets distributor markets bmsuscqpagelucene medicines careers press releases medical information previous page icon previous page icon our medicines patients caregivers next page icon patients caregivers our medicines get help paying for your medicines patient resources risk evaluation and mitigation strategies rems quick links immunology patient resources our position on generic drugs our position on drug pricing psoriasis around the world healthcare providers next page icon healthcare providers learn about pre approval access learn about post study drug access 340b practice fact sheet quick links u s medical information clinical trials pre approval access request system post study drug access request system researchers next page icon researchers areas of focus in the pipeline our r d team our efforts in stem clinical trials research independent research the thomas o daniel research incubator and collaboration center quick links perspectives from our head of research research publications disclosure commitment investigator sponsored research portal areas of interest competitive research grants compound technology requests data sharing request process investors next page icon investors stock information financial reporting analyst coverage events and presentations shareholder services acquisition related information for celgene shareholders investor contacts bristol myers squibb completes global strategic license and collaboration agreement with systimmune for bl b01d1 enhancing presence in the adc space quick links annual report 2022 dividend history stock split history investment return calculator sec filings quarterly results product sales summary annual reports annual meeting of shareholders business development next page icon business development our partnerships why partner with us areas of interest business development leadership team begin a discussion global alliances leadership team early innovation at bms quick links download business development brochure golden ticket contests news next page icon news press releases our stories medical meetings media library media contacts quick links scientific media resources disease state infographics corporate publications about us next page icon about us our company leadership global inclusion diversity responsibility sustainability contact us quick links global patient week survivorship today history timeline worldwide locations the bristol myers squibb foundation people business resource groups our commitment to global inclusion and diversity position on key issues global biopharmaceutical company bristol myers squibb bristol myers squibb completes transaction with mirati therapeutics we announced that we completed our transaction with mirati therapeutics an important milestone as we continue to strengthen and diversify our oncology portfolio together we will build on our long legacy of pioneering innovations in cancer treatments to transform the lives of patients it was something i ll never forget first time c2c4c riders challenge themselves throughout the world to help cancer patients celebrating latin america s women in stem three bms colleagues from mexico brazil and argentina all felt a pull to pursue science and technology they share how they defied stereotypes to turn their fascinations into meaningful careers explore bms 2023 fourth quarter and full year financial results how bms is closing the diversity gap in clinical trials one woman s account of living with ulcerative colitis researching lung cancer treatments to give more patients better outcomes science firsthand the pathway to drug discovery scientific media resources our scientists are driven by curiosity to pursue the best outcomes possible for patients explore our strategic research approaches that allow us to investigate the potential of our early discoveries no matter the platform or modality advancing cell therapy shaping our approach today to reach more patients tomorrow global inclusion diversity leading with our value of inclusion read the report moving forward together survivorship today explore what it means to live with cancer in a series of conversations with survivors from across the country learn more careers we re looking for people who want to change lives join us as we transform patients lives through science learn more investors learn more about how we strive to produce sustained strong performance and shareholder value learn more looking for answers quick links to helpful resources clinical trial information for researchers clinical trials and research are a critical part of bringing new medicines to patients learn more find a clinical trial medical information for healthcare providers information and resources to assist with caring for patients resources for u s healthcare providers global medical information help paying for your medicines if you are a patient in the u s struggling to understand your coverage or pay for your medication we may be able to help find out how main navigation home patients caregivers healthcare providers researchers investors news about us resources our medicines legal notice privacy notice trademarks forward looking statement uk ca slavery and human trafficking statement pdf follow us careers our stories contact us worldwide locations february 08 2024 2024 bristol myers squibb company
|